Communiqués CelLBxHealth plc

Actions

CLBX

GB0034330679

Equipement et technologie médicale avancés

Marché Fermé - London S.E. 17:35:04 21/08/2026			Varia. 5j.	Varia. 1 janv.
1,250 ^GBX	-5,66%		-5,66%	+13,64%

11/08	Actualités East Star Verkhuba ; accord de distribution pour BSF	AN
11/08	CelLBxHealth plc publie une étude évaluée par les pairs démontrant le potentiel diagnostique et de suivi des CTC enrichies par Parsortix dans le glioblastome	CI

Communiqués

30/10/25	ANGLE plc - Change of Name	AQ
10/09/25	Presentation slides 9 September 2025: Interim Results for the six months ended 30 June 2025	PU
11/06/25	ANGLE PLC - PARSORTIX SYSTEM enableS novel DISCOVERIES into the biology of cancer	AQ
10/06/25	ANGLE : Sustainability and ESG strategy overview 2024	PU
06/06/25	ANGLE : Annual Report December 2024	PU
29/05/25	ANGLE plc - Preliminary Results for the year ended 31 December 2024	AQ
24/03/25	ANGLE plc - Issue of LTIP Options and Share Options	AQ
24/03/25	ANGLE PLC - UPDATE ON ASTRAZENECA ASSAY DEVELOPMENT PROJECTS AND SUCCESSFUL COMPLETION OF EISAI CONTRACT	AQ
21/03/25	Angle PLC Announces Results of Eisai Phase 2 pilot study	AQ
21/03/25	Angle PLC Announces Issue of LTIP Options and Share Options	AQ
27/01/25	ANGLE PLC - CLINICAL TRIAL POWERED BY PARSORTIX SYSTEM PROVIDES FIRST-IN-CLASS data FOR NOVEL APPROACH TO CANCER treatment	AQ
16/12/24	ANGLE PLC - WEILL CORNELL MEDICINE PRESENTS HER2 PARSORTIX WORKFLOW AT SAN ANTONIO BREAST CANCER SYMPOSIUM	AQ
18/11/24	ANGLE plc - parsortix-based pd-l1 assay showcased at international liquid biopsy conference	AQ
18/11/24	ANGLE PLC - RESULTS FROM WORK TO DEVELOP A PARSORTIX-BASED Her2 assay KIT SHOWCASED AT INTERNATIONAL LIQUID BIOPSY CONFERENCE	AQ
12/11/24	ANGLE plc - DNA analysis of Parsortix-enriched CTCs and ctDNA provides complementary information in NSCLC patients treated with AstraZeneca's osimertinib	AQ
29/10/24	ANGLE : Presentation slides introduction for new investors Proactive Investors Event 24 October 2024	PU
23/10/24	ANGLE : Interim Report June 2024	PU
27/09/24	ANGLE PLC - 100TH PUBLICATION SUPPORTING PARSORTIX SYSTEM USE	AQ
26/09/24	Presentation slides 26 September 2024: Interim Results for the six months ended 30 June 2024	PU
24/09/24	ANGLE ANNOUNCES NEXT GENERATION SEQUENCING ASSAY AGREEMENT WITH NUPROBE	AQ
20/09/24	ANGLE plc - AGREEMENT WITH RECURSION PHARMACEUTICALS	AQ
18/09/24	ANGLE plc - Notice of Interim Results and Webcast	AQ
09/09/24	ANGLE : Webcast Shares Investor Event 3 September 2024	PU
05/07/24	ANGLE : Sustainability and ESG strategy overview 2023	PU
18/06/24	ANGLE : Annual Report December 2023	PU